EPIVAX ONCOLOGY, INC.
USPTO Trademark & Patent Filings
Trademark applications and grants for Epivax Oncology, Inc.. Epivax Oncology, Inc. has 3 trademark applications. The latest application filed is for "ANCER"
- Company Aliases
- EPIVAX ONCOLOGY, INC.
- Epivax Oncology, Inc. - New York NY US
| State Incorporated | RHODE ISLAND |
| Entity Type | CORPORATION |
| Address | 188 Valley Street Providence, RHODE ISLAND UNITED STATES 02909 |
Trademarks Patents
| Patent Application | Date |
|---|---|
| NEO-EPITOPE VACCINES AND METHODS OF TREATING CANCER 20210154280 - 16/951722 Martin; William D. ; et al. | 2021-05-27 |
| COMPOSITIONS AND METHODS FOR SHARED NEO-EPITOPE VACCINES 20210145951 - 16/951703 Martin; William D. ; et al. | 2021-05-20 |
Mark Image Registration | Serial | Trademark Application Date |
|---|---|
"ANCER" 90476634 |
ANCER 2021-01-20 |
"EPIVAX ONCOLOGY" 5938527 87561735 |
EPIVAX ONCOLOGY 2017-08-09 |
"ANCER" 87982539 |
ANCER 2017-01-09 |
| NCAGE Code | 88T10 | EPIVAX ONCOLOGY, INC. |
| CAGE Code | 88T10 | EPIVAX ONCOLOGY, INC. |
| S.A.M. Registration | 88T10 [116965366] | EPIVAX ONCOLOGY, INC. |
| DUNS | 116965366 | Epivax Oncology, Inc. |
| SEC | 0001724741 | EpiVax Oncology, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 